Trump, Autism and Food and Drug Administration
Digest more
Trump’s 100% Tariff On Pharma To Harm Only US, Not India
Digest more
The Food and Drug Administration will review evidence about the safety and efficacy of the abortion drug Mifepristone.
Donald Trump went after Tylenol again in a Truth Social post Friday, urging pregnant women to avoid the drug, causing parent company Kenvue’s shares to slip. President Trump warned women to avoid Tylenol “unless absolutely necessary” in a post on Truth Social Friday.
WJW-TV Cleveland on MSN
Baby food recalled in NY, NJ, and other states: FDA
A voluntary recall is in place for a popular baby food sold mostly at a national drug store, according to a company announcement found on the Food and Drug Administration’s website. Sprout Organics has initiated a voluntary recall of one of its products sold at Walgreens.
The US Food and Drug Administration is reviewing evidence about the safety and efficacy of mifepristone, one of the drugs used in medication abortion, to investigate how it can be safely dispensed, US Health and Human Services Secretary Robert F.
Consumers are advised to check the expiration date and lot code on the bottom strip of the pouch to determine if their product is part of the recall.
The questionable shrimp was sold between June 12, 2025, and September 17, 2025, at several major stores, including Food 4 Less, Foodsco, Fred Meyer, Ralph’s, Kroger, and Mariano’s, and distributed in 31 states.
Thune said he believes decisions about health "ought to be grounded in science" after he was asked about Trump's claim linking autism to Tylenol use.
Crinetics Pharmaceuticals won FDA approval for a drug to treat acromegaly, a rare and debilitating hormonal disorder.
A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially providing an easier alternative to Ozempic injections.
Suitability Petition is required for shift from multidose packaging of ketamine to single-patient dose preservative free ketamineGranting of Suitability Petition enables re-filing of Abbreviated New Drug Application (ANDA) for NRx’s patent-pending preservative-free ketamine product WILMINGTON,